Literature DB >> 32701617

The interaction between the complement system and hemostatic factors.

Selin Oncul1, Vahid Afshar-Kharghan2.   

Abstract

PURPOSE OF REVIEW: To discuss the crosstalk between the complement system and hemostatic factors (coagulation cascade, platelet, endothelium, and Von Willebrand Factor), and the consequences of this interaction under physiologic and pathologic conditions. RECENT
FINDINGS: The complement and coagulation systems are comprised of serine proteases and are genetically related. In addition to the common ancestral genes, the complement system and hemostasis interact directly, through protein-protein interactions, and indirectly, on the surface of platelets and endothelial cells. The close interaction between the complement system and hemostatic factors is manifested both in physiologic and pathologic conditions, such as in the inflammatory response to thrombosis, thrombosis at the inflamed area, and thrombotic complications of complement disorders.
SUMMARY: The interaction between the complement system and hemostasis is vital for homeostasis and the protective response of the host to tissue injury, but also results in the pathogenesis of several thrombotic and inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32701617      PMCID: PMC7773221          DOI: 10.1097/MOH.0000000000000605

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.218


  183 in total

Review 1.  Complement: more than a 'guard' against invading pathogens?

Authors:  Dimitrios Mastellos; John D Lambris
Journal:  Trends Immunol       Date:  2002-10       Impact factor: 16.687

Review 2.  Biological activities of C1 inhibitor.

Authors:  Alvin E Davis; Pedro Mejia; Fengxin Lu
Journal:  Mol Immunol       Date:  2008-07-31       Impact factor: 4.407

Review 3.  Coagulation and innate immune responses: can we view them separately?

Authors:  Mieke Delvaeye; Edward M Conway
Journal:  Blood       Date:  2009-07-07       Impact factor: 22.113

4.  Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes.

Authors:  D E Dunn; P Tanawattanacharoen; P Boccuni; S Nagakura; S W Green; M R Kirby; M S Kumar; S Rosenfeld; N S Young
Journal:  Ann Intern Med       Date:  1999-09-21       Impact factor: 25.391

5.  Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.

Authors:  S Meri; B P Morgan; A Davies; R H Daniels; M G Olavesen; H Waldmann; P J Lachmann
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

6.  Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis.

Authors:  J Passwell; G F Schreiner; M Nonaka; H U Beuscher; H R Colten
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

7.  Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.

Authors:  A Nicholson-Weller; J Burge; K F Austen
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

8.  Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals.

Authors:  Mette Møller-Kristensen; Jens Chr Jensenius; Lisbeth Jensen; Nicole Thielens; Véronique Rossi; Gerard Arlaud; Steffen Thiel
Journal:  J Immunol Methods       Date:  2003-11       Impact factor: 2.303

9.  Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin.

Authors:  Jan-Dirk Studt; Johanna A Kremer Hovinga; Gerhard Antoine; Martin Hermann; Manfred Rieger; Friedrich Scheiflinger; Bernhard Lämmle
Journal:  Blood       Date:  2004-09-14       Impact factor: 22.113

10.  C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation.

Authors:  Leendert A Trouw; Sara C Nilsson; Isabel Gonçalves; Göran Landberg; Anna M Blom
Journal:  J Exp Med       Date:  2005-06-20       Impact factor: 14.307

View more
  5 in total

Review 1.  Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology.

Authors:  Paola Rampelotto Ziani; Jacson Gabriel Feiten; Jéferson Ferraz Goularte; Rafael Colombo; Bárbara Antqueviezc; Luiza Paul Géa; Adriane Ribeiro Rosa
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

2.  Novel Inhibitors and Activity-Based Probes Targeting Trypsin-Like Serine Proteases.

Authors:  Timothy E G Ferguson; James A Reihill; S Lorraine Martin; Brian Walker
Journal:  Front Chem       Date:  2022-04-21       Impact factor: 5.545

3.  A Rare Case of HELLP Syndrome with Hematomas of Spleen and Liver, Eclampsia, Severe Hypertension and Prolonged Coagulopathy-A Case Report.

Authors:  Małgorzata Lewandowska; Monika Englert-Golon; Zbigniew Krasiński; Paweł Piotr Jagodziński; Stefan Sajdak
Journal:  Int J Environ Res Public Health       Date:  2022-06-23       Impact factor: 4.614

4.  Salvianolic acid A alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting complement activation.

Authors:  Qi-Yun Zhang; Jing Guo; Lin Xu; Ying Wei; Shu-Ting Zhou; Qing-Yu Lu; Li Guo; Qian-Yun Sun
Journal:  BMC Complement Med Ther       Date:  2022-09-20

Review 5.  Immune Modulation in Critically Ill Septic Patients.

Authors:  Salvatore Lucio Cutuli; Simone Carelli; Domenico Luca Grieco; Gennaro De Pascale
Journal:  Medicina (Kaunas)       Date:  2021-05-31       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.